Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan
Article in Infectious Diseases and Therapy (April 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Infectious Diseases and Therapy (April 2024)
Article in Hepatology International (January 2024)
Article in Journal of Virus Eradication (November 2023)